Skip to main content

Advertisement

SpringerLink
Log in

Current Perspectives on Erythema Multiforme

  • Published:
Clinical Reviews in Allergy & Immunology Aims and scope Submit manuscript

Abstract

Recognition and timely adequate treatment of erythema multiforme remain a major challenge. In this review, current diagnostic guidelines, potential pitfalls, and modern/novel treatment options are summarized with the aim to help clinicians with diagnostic and therapeutic decision-making. The diagnosis of erythema multiforme, that has an acute, self-limiting course, is based on its typical clinical picture of targetoid erythematous lesions with predominant acral localization as well as histological findings. Clinically, erythema multiforme can be differentiated into isolated cutaneous and combined mucocutaneous forms. Atypical erythema multiforme manifestations include lichenoid or granulomatous lesions as well as lesional infiltrates of T cell lymphoma and histiocytes. Herpes simplex virus infection being the most common cause, other infectious agents like—especially in children—Mycoplasma pneumoniae, hepatitis C virus, Coxsackie virus, and Epstein Barr virus may also trigger erythema multiforme. The second most frequently identified cause of erythema multiforme is drugs. In different studies, e.g., allopurinol, phenobarbital, phenytoin, valproic acid, antibacterial sulfonamides, penicillins, erythromycin, nitrofurantoin, tetracyclines, chlormezanone, acetylsalicylic acid, statins, as well as different TNF-α inhibitors such as adalimumab, infliximab, and etanercept were reported as possible implicated drugs. Recently, cases of erythema multiforme associated with vaccination, immunotherapy for melanoma, and even with topical drugs like imiquimod have been described. In patients with recurrent herpes simplex virus-associated erythema multiforme, the topical prophylactic treatment with acyclovir does not seem to prevent further episodes of erythema multiforme. In case of resistance to one virostatic drug, the switch to an alternative drug, and in patients non-responsive to virostatic agents, the use of dapsone as well as new treatment options, e.g., JAK-inhibitors or apremilast, might be considered.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  1. Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC (1993) Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 129(1):92–96. https://doi.org/10.1001/archderm.1993.01680220104023

    Article  CAS  PubMed  Google Scholar 

  2. Gossart R, Malthiery E, Aguilar F, Torres JH, Fauroux MA (2017) Fuchs syndrome: medical treatment of 1 case and literature review. Case Rep Dermatol 9(1):114–120. https://doi.org/10.1159/000468978

    Article  PubMed  PubMed Central  Google Scholar 

  3. Havliza K, Jakob A, Rompel R (2009) Erythema multiforme majus (Fuchs syndrome) associated with Mycoplasma pneumoniae infection in two patients. J Dtsch Dermatol Ges = J German Soc Dermatol: JDDG 7(5):445–448. https://doi.org/10.1111/j.1610-0387.2008.06978.x

    Google Scholar 

  4. Wetter DA, Davis MD (2010) Recurrent erythema multiforme: clinical characteristics, etiologic associations, and treatment in a series of 48 patients at Mayo Clinic, 2000 to 2007. J Am Acad Dermatol 62(1):45–53. https://doi.org/10.1016/j.jaad.2009.06.046

    Article  CAS  PubMed  Google Scholar 

  5. Auquier-Dunant A, Mockenhaupt M, Naldi L, Correia O, Schroder W, Roujeau JC (2002) Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study. Arch Dermatol 138(8):1019–1024

    Article  PubMed  Google Scholar 

  6. Assier H, Bastuji-Garin S, Revuz J, Roujeau JC (1995) Erythema multiforme with mucous membrane involvement and Stevens-Johnson syndrome are clinically different disorders with distinct causes. Arch Dermatol 131(5):539–543. https://doi.org/10.1001/archderm.1995.01690170041005

    Article  CAS  PubMed  Google Scholar 

  7. Ng PP, Sun YJ, Tan HH, Tan SH (2003) Detection of herpes simplex virus genomic DNA in various subsets of erythema multiforme by polymerase chain reaction. Dermatology (Basel, Switzerland) 207(4):349–353. https://doi.org/10.1159/000074112

    Article  CAS  Google Scholar 

  8. Aurelian L, Ono F, Burnett J (2003) Herpes simplex virus (HSV)-associated erythema multiforme (HAEM): a viral disease with an autoimmune component. Dermatol Online J 9(1):1

    CAS  PubMed  Google Scholar 

  9. Komorowski L, Mockenhaupt M, Sekula P, Roujeau JC, Probst C, Teegen B, Li W, Stocker W, Zillikens D (2013) Lack of a specific humoral autoreactivity in sera from patients with early erythema exsudativum multiforme majus. J Invest Dermatol 133(12):2799–2802. https://doi.org/10.1038/jid.2013.242

    Article  CAS  PubMed  Google Scholar 

  10. Ono F, Sharma BK, Smith CC, Burnett JW, Aurelian L (2005) CD34+ cells in the peripheral blood transport herpes simplex virus DNA fragments to the skin of patients with erythema multiforme (HAEM). J Invest Dermatol 124(6):1215–1224. https://doi.org/10.1111/j.0022-202X.2005.23712.x

    Article  CAS  PubMed  Google Scholar 

  11. Kampgen E, Burg G, Wank R (1988) Association of herpes simplex virus-induced erythema multiforme with the human leukocyte antigen DQw3. Arch Dermatol 124(9):1372–1375. https://doi.org/10.1001/archderm.1988.01670090028005

    Article  CAS  PubMed  Google Scholar 

  12. Miller PK, Zain-Ul-Abideen M, Paul J, Perry AE, Linos K, Carter JB, Kurtzberg J, Mann JA (2017) A case of eczema coxsackium with erythema multiforme-like histopathology in a 14-year-old boy with chronic graft-versus-host disease. JAAD Case Rep 3(1):49–52. https://doi.org/10.1016/j.jdcr.2016.11.007

    Article  PubMed  PubMed Central  Google Scholar 

  13. Siedner-Weintraub Y, Gross I, David A, Reif S, Molho-Pessach V (2017) Paediatric erythema multiforme: epidemiological, clinical and laboratory characteristics. Acta Derm Venereol 97(4):489–492. https://doi.org/10.2340/00015555-2569

    Article  PubMed  Google Scholar 

  14. Schalock PC, Dinulos JG, Pace N, Schwarzenberger K, Wenger JK (2006) Erythema multiforme due to Mycoplasma pneumoniae infection in two children. Pediatr Dermatol 23(6):546–555. https://doi.org/10.1111/j.1525-1470.2006.00307.x

    Article  PubMed  Google Scholar 

  15. Canavan TN, Mathes EF, Frieden I, Shinkai K (2015) Mycoplasma pneumoniae-induced rash and mucositis as a syndrome distinct from Stevens-Johnson syndrome and erythema multiforme: a systematic review. J Am Acad Dermatol 72(2):239–245. https://doi.org/10.1016/j.jaad.2014.06.026

    Article  PubMed  Google Scholar 

  16. Messina MF, Cannavo SP, Aversa S, De Luca F (2011) Transient natural killer deficiency in a boy with herpes simplex virus-associated recurrent erythema multiforme. Scand J Infect Dis 43(6–7):550–552. https://doi.org/10.3109/00365548.2011.560185

    Article  PubMed  Google Scholar 

  17. Turnbull N, Hawkins D, Atkins M, Francis N, Roberts N (2014) Persistent erythema multiforme associated with Epstein-Barr virus infection. Clin Exp Dermatol 39(2):154–157. https://doi.org/10.1111/ced.12243

    Article  CAS  PubMed  Google Scholar 

  18. Drago F, Parodi A, Rebora A (1995) Persistent erythema multiforme: report of two new cases and review of literature. J Am Acad Dermatol 33(2 Pt 2):366–369. https://doi.org/10.1016/0190-9622(95)91435-8

    Article  CAS  PubMed  Google Scholar 

  19. Chan HL, Stern RS, Arndt KA, Langlois J, Jick SS, Jick H, Walker AM (1990) The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients. Arch Dermatol 126(1):43–47. https://doi.org/10.1001/archderm.1990.01670250049006

    Article  CAS  PubMed  Google Scholar 

  20. Shabahang L (2010) Characteristics of adult outpatients with erythema multiforme. Pak J Biol Sci: PJBS 13(22):1106–1109

    Article  PubMed  Google Scholar 

  21. Kaur S, Handa S (2008) Erythema multiforme following vaccination in an infant. Indian J Dermatol Venereol Leprol 74(3):251–253. https://doi.org/10.4103/0378-6323.41373

    Article  PubMed  Google Scholar 

  22. Monastirli A, Pasmatzi E, Badavanis G, Tsambaos D (2017) Erythema multiforme following pneumococcal vaccination. Acta Dermatovenerol Alp Pannonica Adriat 26(1):25–26

    PubMed  Google Scholar 

  23. Ahdout J, Haley JC, Chiu MW (2010) Erythema multiforme during anti-tumor necrosis factor treatment for plaque psoriasis. J Am Acad Dermatol 62(5):874–879. https://doi.org/10.1016/j.jaad.2009.04.048

    Article  PubMed  Google Scholar 

  24. Kimura T, Sowa-Osako J, Nakai T, Ohyama A, Kawaguchi T, Tsuruta D, Ohsawa M, Hirata K (2016) Alectinib-induced erythema multiforme and successful rechallenge with alectinib in a patient with anaplastic lymphoma kinase-rearranged lung cancer. Case Rep Oncol 9(3):826–832. https://doi.org/10.1159/000453314

    Article  PubMed  PubMed Central  Google Scholar 

  25. Nomura H, Takahashi H, Suzuki S, Kurihara Y, Chubachi S, Kawada I, Yasuda H, Betsuyaku T, Amagai M, Funakoshi T (2017) Unexpected recalcitrant course of drug-induced erythema multiforme-like eruption and interstitial pneumonia sequentially occurring after nivolumab therapy. J Dermatol 44(7):818–821. https://doi.org/10.1111/1346-8138.13810

    Article  CAS  PubMed  Google Scholar 

  26. Rodriguez-Pazos L, Sanchez-Aguilar D, Rodriguez-Granados MT, Pereiro-Ferreiros MM, Toribio J (2010) Erythema multiforme photoinduced by statins. Photodermatol Photoimmunol Photomed 26(4):216–218. https://doi.org/10.1111/j.1600-0781.2010.00519.x

    Article  PubMed  Google Scholar 

  27. Yanes DA, Kaffenberger JA, Carr DR (2017) Erythema multiforme as a reaction to imiquimod 5% cream. Dermatol Online J 23(2)

  28. Gehanno JF, Priot AE, Balguerie X, Caillard JF (2006) Polyhexamethylenebiguanide hydrochloride exposure and erythema multiforme in a physician. Int J Occup Med Environ Health 19(1):81–82

    Article  PubMed  Google Scholar 

  29. Nasabzadeh TJ, Stefanato CM, Doole JE, Radfar A, Bhawan J, Venna S (2010) Recurrent erythema multiforme triggered by progesterone sensitivity. J Cutan Pathol 37(11):1164–1167. https://doi.org/10.1111/j.1600-0560.2010.01607.x

    Article  PubMed  Google Scholar 

  30. Grunnet KM, Powell KS, Miller IA, Davis LS (2017) Autoimmune progesterone dermatitis manifesting as mucosal erythema multiforme in the setting of HIV infection. JAAD Case Rep 3(1):22–24. https://doi.org/10.1016/j.jdcr.2016.10.010

    Article  PubMed  Google Scholar 

  31. Elcin G, Gulseren D, Bayraktar M, Gunalp S, Gurgan T (2017) Autoimmune estrogen dermatitis in an infertile female. Cutan Ocul Toxicol 36(2):195–198. https://doi.org/10.1080/15569527.2016.1245197

    Article  CAS  PubMed  Google Scholar 

  32. Begolli Gerqari AM, Ferizi M, Halimi S, Daka A, Hapciu S, Begolli IM, Begolli M, Hysen Gerqari I (2016) Erythema exsudativum multiforme induced by a taurine-containing energy drink. Acta Dermatovenerol Alp Pannonica Adriat 25(4):83–84

    PubMed  Google Scholar 

  33. Rowell NR, Beck JS, Anderson JR (1963) Lupus erythematosus and erythema multiforme-like lesions. A syndrome with characteristic immunological abnormalities. Arch Dermatol 88(2):176–180. https://doi.org/10.1001/archderm.1963.01590200064012

    Article  CAS  PubMed  Google Scholar 

  34. Shteyngarts AR, Warner MR, Camisa C (1999) Lupus erythematosus associated with erythema multiforme: does Rowell’s syndrome exist? J Am Acad Dermatol 40(5 Pt 1):773–777. https://doi.org/10.1016/S0190-9622(99)70165-9

    Article  CAS  PubMed  Google Scholar 

  35. Aydogan K, Karadogan S, Balaban Adim S, Tunali S (2005) Lupus erythematosus associated with erythema multiforme: report of two cases and review of the literature. J Eur Acad Dermatol Venereol: JEADV 19(5):621–627. https://doi.org/10.1111/j.1468-3083.2005.01233.x

    Article  CAS  PubMed  Google Scholar 

  36. Lee A, Batra P, Furer V, Cheung W, Wang N, Franks A Jr (2009) Rowell syndrome (systemic lupus erythematosus + erythema multiforme). Dermatol Online J 15(8):1

    PubMed  Google Scholar 

  37. Duarte AF, Mota A, Pereira M, Baudrier T, Azevedo F (2008) Rowell syndrome—case report and review of the literature. Dermatol Online J 14(3):15

    CAS  Google Scholar 

  38. Parodi A, Drago EF, Varaldo G, Rebora A (1989) Rowell's syndrome. Report of a case. J Am Acad Dermatol 21(2 Pt 2):374–377. https://doi.org/10.1016/S0190-9622(89)80038-6

    Article  CAS  PubMed  Google Scholar 

  39. Zeitouni NC, Funaro D, Cloutier RA, Gagne E, Claveau J (2000) Redefining Rowell’s syndrome. Br J Dermatol 142(2):343–346. https://doi.org/10.1046/j.1365-2133.2000.03306.x

    Article  CAS  PubMed  Google Scholar 

  40. Fraser-Andrews EA, Morris-Jones R, Novakovic L, Hawk JL (2005) Erythema multiforme following polymorphic light eruption: a report of two cases. Clin Exp Dermatol 30(3):232–234. https://doi.org/10.1111/j.1365-2230.2004.01707.x

    Article  CAS  PubMed  Google Scholar 

  41. Czarnecka-Operacz M, Jenerowicz D, Szulczynska-Gabor J, Teresiak-Mikolajczak E, Szyfter-Harris J, Bowszyc-Dmochowska M (2016) Vesicular contact reaction may progress into erythema multiforme. Acta Dermatovenerol Croat: ADC 24(4):307–309

    PubMed  Google Scholar 

  42. Wolf R, Stander S, Well O, Frey L, Klier I, Brunner S, Flaig M, Wollenberg A, Ruzicka T (2017) Pustular erythema multiforme major associated with atypical pneumonia. J Eur Acad Dermatol Venereol: JEADV 31(11):e502–e503. https://doi.org/10.1111/jdv.14356

    Article  CAS  PubMed  Google Scholar 

  43. Behera B, Kumari R, Gochhait D, Thappa DM (2017) Generalized lichen planus developing at the healed sites of erythema multiforme in a human immunodeficiency virus-seropositive patient. Indian J Dermatol Venereol Leprol 83(4):485–489. https://doi.org/10.4103/ijdvl.IJDVL_268_16

    Article  PubMed  Google Scholar 

  44. Elm MK, Murchland MR (2012) Multifocal, fixed-drug eruption masquerading as recurrent erythema multiforme. J Drugs Dermatol: JDD 11(2):244–246

    PubMed  Google Scholar 

  45. Beer K, Beer MS, Appelbaum D (2013) Granuloma annulare masquerading as erythema multiforme. J Drugs Dermatol: JDD 12(6):694–697

    PubMed  Google Scholar 

  46. Ohtani T, Deguchi M, Aiba S (2008) Erythema multiforme-like lesions associated with lesional infiltration of tumor cells occurring with adult T-cell lymphoma/leukemia. Int J Dermatol 47(4):390–392. https://doi.org/10.1111/j.1365-4632.2008.03535.x

    Article  PubMed  Google Scholar 

  47. Michigami M, Kabashima K, Nonaka Y, Kamoda Y, Yoshinaga T, Kudo H (2012) Kikuchi-Fujimoto disease with recurrent fever and erythema multiforme-like lesions. Eur J Dermatol: EJD 22(2):263–264. https://doi.org/10.1684/ejd.2011.1628

    PubMed  Google Scholar 

  48. Chua SH, Giam YC, Sim CS (1996) Systemic lupus erythematosus with erythema multiforme-like lesions and histiocytic necrotizing lymphadenitis—a case report. Ann Acad Med Singap 25(4):599–601

    CAS  PubMed  Google Scholar 

  49. Sebastian A, Patterson C, Zaenglein AL, Ioffreda MD, Helm KF (2009) Histiocytic erythema multiforme. J Cutan Pathol 36(12):1323–1325. https://doi.org/10.1111/j.1600-0560.2009.01287.x

    Article  PubMed  Google Scholar 

  50. Rzany B, Mockenhaupt M, Baur S, Schroder W, Stocker U, Mueller J, Hollander N, Bruppacher R, Schopf E (1996) Epidemiology of erythema exsudativum multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis in Germany (1990-1992): structure and results of a population-based registry. J Clin Epidemiol 49(7):769–773. https://doi.org/10.1016/0895-4356(96)00035-2

    Article  CAS  PubMed  Google Scholar 

  51. Ackerman AB, Penneys NS, Clark WH (1971) Erythema multiforme exudativum: distinctive pathological process. Br J Dermatol 84(6):554–566

    Article  CAS  PubMed  Google Scholar 

  52. Ackerman AB, Ragaz A (1985) Erythema multiforme. Am J Dermatopathol 7(2):133–139

    Article  CAS  PubMed  Google Scholar 

  53. Lever WF (1985) My concept of erythema multiforme. Am J Dermatopathol 7(2):141–142. https://doi.org/10.1097/00000372-198504000-00008

    Article  CAS  PubMed  Google Scholar 

  54. Orfanos CE, Schaumburg-Lever G, Lever WF (1974) Dermal and epidermal types of erythema multiforme. A histopathologic study of 24 cases. Arch Dermatol 109(5):682–688. https://doi.org/10.1001/archderm.1974.01630050028006

    Article  CAS  PubMed  Google Scholar 

  55. Cote B, Wechsler J, Bastuji-Garin S, Assier H, Revuz J, Roujeau JC (1995) Clinicopathologic correlation in erythema multiforme and Stevens-Johnson syndrome. Arch Dermatol 131(11):1268–1272. https://doi.org/10.1001/archderm.1995.01690230046008

    Article  CAS  PubMed  Google Scholar 

  56. Tatnall FM, Schofield JK, Leigh IM (1995) A double-blind, placebo-controlled trial of continuous acyclovir therapy in recurrent erythema multiforme. Br J Dermatol 132(2):267–270

    Article  CAS  PubMed  Google Scholar 

  57. Lemak MA, Duvic M, Bean SF (1986) Oral acyclovir for the prevention of herpes-associated erythema multiforme. J Am Acad Dermatol 15(1):50–54. https://doi.org/10.1016/S0190-9622(86)70141-2

    Article  CAS  PubMed  Google Scholar 

  58. Fawcett HA, Wansbrough-Jones MH, Clark AE, Leigh IM (1983) Prophylactic topical acyclovir for frequent recurrent herpes simplex infection with and without erythema multiforme. Br Med J (Clin Res Ed) 287(6395):798–799. https://doi.org/10.1136/bmj.287.6395.798-a

    Article  CAS  Google Scholar 

  59. Staikuniene J, Staneviciute J (2015) Long-term valacyclovir treatment and immune modulation for herpes-associated erythema multiforme. Cen Eur J Immunol 40(3):387–390. https://doi.org/10.5114/ceji.2015.54604

    Article  Google Scholar 

  60. Routt E, Levitt J (2014) Famciclovir for recurrent herpes-associated erythema multiforme: a series of three cases. J Am Acad Dermatol 71(4):e146–e147. https://doi.org/10.1016/j.jaad.2014.05.029

    Article  PubMed  Google Scholar 

  61. Kieny A, Lipsker D (2016) Efficacy of interferon in recurrent valaciclovir-refractory erythema multiforme in a patient not infected with hepatitis C virus. Clin Exp Dermatol 41(6):648–650. https://doi.org/10.1111/ced.12871

    Article  CAS  PubMed  Google Scholar 

  62. Oak AS, Seminario-Vidal L, Sami N (2017) Treatment of antiviral-resistant recurrent erythema multiforme with dapsone. Dermatol Ther 30(2). https://doi.org/10.1111/dth.12449

  63. Sen P, Chua SH (2004) A case of recurrent erythema multiforme and its therapeutic complications. Ann Acad Med Singap 33(6):793–796

    CAS  PubMed  Google Scholar 

  64. Bakis S, Zagarella S (2005) Intermittent oral cyclosporin for recurrent herpes simplex-associated erythema multiforme. Australas J Dermatol 46(1):18–20. https://doi.org/10.1111/j.1440-0960.2004.00130.x

    Article  PubMed  Google Scholar 

  65. Baillis B, Maize JC Sr (2017) Treatment of recurrent erythema multiforme with adalimumab as monotherapy. JAAD Case Rep 3(2):95–97. https://doi.org/10.1016/j.jdcr.2016.11.009

    Article  PubMed  PubMed Central  Google Scholar 

  66. Chen CW, Tsai TF, Chen YF, Hung CM (2008) Persistent erythema multiforme treated with thalidomide. Am J Clin Dermatol 9(2):123–127. https://doi.org/10.2165/00128071-200809020-00006

    Article  PubMed  Google Scholar 

  67. Damsky W, King BA (2016) Idiopathic erythema multiforme: evidence of underlying Janus kinase-signal transducer and activator of transcription activation and successful treatment with tofacitinib. JAAD Case Rep 2(6):502–504. https://doi.org/10.1016/j.jdcr.2016.10.009

    Article  PubMed  PubMed Central  Google Scholar 

  68. Chen T, Levitt J, Geller L (2017) Apremilast for treatment of recurrent erythema multiforme. Dermatol Online J 23(1)

Download references

Acknowledgements

We thank Renata Flury, MD, for the histological pictures.

Author information

Authors and Affiliations

  1. Allergy/Dermatology Unit, Department of Internal Medicine, Kantonsspital Winterthur, Winterthur, Switzerland

    Marianne Lerch

  2. Department of Dermatology, Bellinzona Regional Hospital, Bellinzona, Switzerland

    Carlo Mainetti

  3. Epatocentro Ticino, Lugano, Switzerland

    Benedetta Terziroli Beretta-Piccoli

  4. Unité d’allergologie, Service d’immunologie et d’allergologie, Hôpitaux Universitaires de Genève HUG, Rue Micheli-du-Crest 24, CH-1211, Genève, Switzerland

    Thomas Harr

Authors
  1. Marianne Lerch
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Carlo Mainetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Benedetta Terziroli Beretta-Piccoli
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Thomas Harr
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Thomas Harr.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Informed Consent

When necessary, informed consent has been collected from patients.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lerch, M., Mainetti, C., Terziroli Beretta-Piccoli, B. et al. Current Perspectives on Erythema Multiforme. Clinic Rev Allerg Immunol 54, 177–184 (2018). https://doi.org/10.1007/s12016-017-8667-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12016-017-8667-7

Keywords

Search

Navigation